Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: permit (124), licence (138), warranty (5), authorization (78), security (90), certification (20), merit (26)

Enzalutamide

Description: Chemotherapy Protocol PROSTATE ENZALUTAMIDE Regimen • Prostate-Enzalutamide Indication • Enzalutamide is recommended within its marketing authorisation as an option for treating metastatic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Enzalutamide.pdf

Awake craniotomy - patient information

Description: This factsheet contains information about having an awake craniotomy operation.
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Awake-craniotomy-1194-PIL.pdf

Gilteritinib

Description: Chemotherapy Protocol Acute Myeloid Leukaemia GILTERITINIB Regimen  AML - Gilteritinib Indication Gilteritinib for treating relapsed/refractory FLT3 mutation positive myeloid leukaemia in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Gilteritinib.pdf

Craniotomy for brain tumour removal - patient information

Description: A craniotomy is an operation where a disc of bone is removed from the skull using special tools to allow access
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Craniotomy-for-brain-tumour-removal-1192-PIL.pdf

Image guided biopsy for brain tumour - patient information

Description: Patient information factsheet Image-guided biopsy for a brain tumour We've given you this factsheet because you are due to have an image-guided biopsy. This operation helps us to diagnose tumours in the brain. We hope this factshe
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Image-guided-biopsy-for-brain-tumour-2130-PIL.pdf

BEACON protocol v8.0 07Mar2023 signed

Description: A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Apalutamide v1

Description: Chemotherapy Protocol PROSTATE APALUTAMIDE Regimen  Prostate cancer Indication  Apalutamide is recommended for non-metastatic prostate cancer as defined by recent imaging
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Apalutamide-v1.pdf

2025 WRES report and action plan

Description: Workforce Race Equality Standard Annual Report 2025 1 Executive Summary WRES Data has been submitted by the Trust since 2015 and
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/2025-wres-report-and-action-plan.pdf

Papers Trust Board - 15 July 2025

Description: Agenda Trust Board – Open Session Date 15/07/2025 Time 9:00 - 13:00 Location Conference Room, Heartbeat Education Centre Chair
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-15-July-2025.pdf

DH IVIg approved indications full guidance July 2011

Description: DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Performance Document Purpose Gateway Reference Title Author Publication Date Target Audienc
Url: /Media/SUHTExtranet/TrustMedicinesFormulary/Forms/DH-IVIg-approved-indications-Full-Guidance-July-2011.pdf

1 to 10 of 16

Previous 1 2 Next